BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of SEK 15.78 billion. The enterprise value is 15.05 billion.

Market Cap	15.78B
Enterprise Value	15.05B

Important Dates

The next estimated earnings date is Wednesday, May 21, 2025.

Earnings Date	May 21, 2025
Ex-Dividend Date	n/a

Share Statistics

BioArctic AB has 88.53 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	74.13M
Shares Outstanding	88.53M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	33.47%
Owned by Institutions (%)	47.25%
Float	53.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	16.47
PS Ratio	61.30
PB Ratio	17.63
P/TBV Ratio	17.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-85.00
EV / Sales	58.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-43.88

Financial Position

The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.06.

Current Ratio	5.75
Quick Ratio	5.65
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -18.24% and return on invested capital (ROIC) is -14.35%.

Return on Equity (ROE)	-18.24%
Return on Assets (ROA)	-12.49%
Return on Invested Capital (ROIC)	-14.35%
Return on Capital Employed (ROCE)	-24.53%
Revenue Per Employee	2.41M
Profits Per Employee	-1.65M
Employee Count	107
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.62% in the last 52 weeks. The beta is -0.71, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.71
52-Week Price Change	-8.62%
50-Day Moving Average	193.80
200-Day Moving Average	184.06
Relative Strength Index (RSI)	44.05
Average Volume (20 Days)	302,978

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of SEK 257.35 million and -177.08 million in losses. Loss per share was -2.00.

Revenue	257.35M
Gross Profit	230.37M
Operating Income	-229.62M
Pretax Income	-189.52M
Net Income	-177.08M
EBITDA	-211.19M
EBIT	-229.62M
Loss Per Share	-2.00

Full Income Statement

Balance Sheet

The company has 778.92 million in cash and 54.23 million in debt, giving a net cash position of 724.69 million or 8.19 per share.

Cash & Cash Equivalents	778.92M
Total Debt	54.23M
Net Cash	724.69M
Net Cash Per Share	8.19
Equity (Book Value)	894.94M
Book Value Per Share	10.13
Working Capital	835.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -316.33 million and capital expenditures -26.64 million, giving a free cash flow of -342.97 million.

Operating Cash Flow	-316.33M
Capital Expenditures	-26.64M
Free Cash Flow	-342.97M
FCF Per Share	-3.87

Full Cash Flow Statement

Margins

Gross margin is 89.51%, with operating and profit margins of -89.22% and -68.81%.

Gross Margin	89.51%
Operating Margin	-89.22%
Pretax Margin	-73.64%
Profit Margin	-68.81%
EBITDA Margin	-82.06%
EBIT Margin	-89.22%
FCF Margin	n/a

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	-1.12%
FCF Yield	-2.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioArctic AB has an Altman Z-Score of 49.41.

Altman Z-Score	49.41
Piotroski F-Score	n/a